Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-11-051989
Filing Date
2011-10-18
Accepted
2011-10-18 17:11:10
Documents
2
Period of Report
2011-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2184
2 POA DOCUMENT poa.txt EX-24.3_394659 1769
  Complete submission text file 0001209191-11-051989.txt   5282
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address
Greene Rick Scott (Reporting) CIK: 0001531483 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 111146274